Investment Team
-
Current Companies
-
Prior Companies
-
Geeta Vemuri, Ph.D.
-
Joined Quaker BioVentures in 2003 and promoted to Partner in 2008
-
Previously: Associate at Toucan Capital, where she was responsible for investments in seed-stage and start-up biotech opportunities. Participated in raising capital and helped start several portfolio companies by identifying technologies from universities. Associate Equity Analyst at SalomonSmithBarney and First Union Securities covering specialty pharmaceuticals and healthcare sectors. Research scientist at The Wistar Institute and postdoctoral fellow at Thomas Jefferson University.
-
Board Responsibilities: Arginetix, Cempra Pharmaceuticals, and Immune Control
-
Board Observer Responsibilities: Optherion, Regado Biosciences, Tengion, and Tranzyme Pharma
-
Prior Board Participation: Cellatope (acquired by Cypress Bioscience) and Protez Pharmaceuticals (acquired by Novartis)
-
Other: Advisory Board of Fox Chase Cancer Center’s Innovation Fund, Advisory Committee of the Sid Martin Biotechnology Incubator, Board of Directors of Southeast BIO, and the Advisory Committee of BioAdvance Greenhouse.
-
Education: M.S. from Central University in India, Ph.D. in Biochemistry from Indian Institute of Sciences, and M.B.A. from the Wharton School of the University of Pennsylvania
